Papoff P, Mancuso M, Barbara C S, Moretti C
Department of Pediatrics, Pediatric Intensive Care Unit, University of Rome "La Sapienza", Italy.
Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2):213-21. doi: 10.1177/039463200702000201.
Vasopressin and its synthetic analog terlipressin are potent vasopressors that could be useful in vasodilatory septic shock. In septic adults, vasopressin-terlipressin have been shown to increase mean arterial pressure and to decrease the necessity for catecholamines. Moreover, low doses of vasopressin, or terlipressin, increase urine output and ameliorate oxygenation. Although pediatric septic shock is more often hypodynamic, both vasopressin and terlipressin have proved to be effective in restoring blood pressure or increasing the diuresis in this setting. The purpose of this review is to summarize the physiology of vasopressin and to report the available evidence for the use of vasopressin or terlipressin in pediatric septic shock in order to make best use in this population. We also report our experience with the continuous infusion of terlipressin in two pediatric patients who developed catecholamine refractory septic shock.
血管加压素及其合成类似物特利加压素是强效血管收缩剂,可能对血管舒张性感染性休克有用。在感染性休克的成人患者中,血管加压素 - 特利加压素已被证明可提高平均动脉压并减少对儿茶酚胺的需求。此外,低剂量的血管加压素或特利加压素可增加尿量并改善氧合。尽管小儿感染性休克更常表现为低动力型,但血管加压素和特利加压素在这种情况下均已被证明可有效恢复血压或增加尿量。本综述的目的是总结血管加压素的生理学,并报告在小儿感染性休克中使用血管加压素或特利加压素的现有证据,以便在该人群中最佳使用。我们还报告了在两名发生儿茶酚胺难治性感染性休克的儿科患者中持续输注特利加压素的经验。